ALKALI METAL SALT COMBINATIONS OF INCOMPATIBLE ACTIVE PHARMACEUTICAL INGREDIENTS
A composition comprises a first active pharmaceutical ingredient, and an ionic liquid. The first active pharmaceutical ingredient can include ibuprofen or naproxen and the ionic liquid can comprise choline. The first active pharmaceutical ingredient and the ionic liquid together form an ionic salt. The composition can further comprise a second active pharmaceutical agent, such as acetaminophen..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 06. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ANDERSON GARY BRUCE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-06, Last update posted on www.tib.eu: 2024-03-19, Last updated: 2024-03-22 |
|---|
| Patentnummer: |
EP4329733 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA001357255 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA001357255 | ||
| 003 | DE-627 | ||
| 005 | 20240322142321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA001357255 | ||
| 035 | |a (EPA)EP4329733 | ||
| 035 | |a (EPA)81654573 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ANDERSON GARY BRUCE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ALKALI METAL SALT COMBINATIONS OF INCOMPATIBLE ACTIVE PHARMACEUTICAL INGREDIENTS |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-06, Last update posted on www.tib.eu: 2024-03-19, Last updated: 2024-03-22 | ||
| 520 | |a A composition comprises a first active pharmaceutical ingredient, and an ionic liquid. The first active pharmaceutical ingredient can include ibuprofen or naproxen and the ionic liquid can comprise choline. The first active pharmaceutical ingredient and the ionic liquid together form an ionic salt. The composition can further comprise a second active pharmaceutical agent, such as acetaminophen. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a BAILEY HOPE PATRICIA |4 aut | |
| 700 | 0 | |a BOGGIA JONATHON MICHAEL |4 aut | |
| 700 | 0 | |a KINTER KEVIN SCOTT |4 aut | |
| 700 | 0 | |a MOORE RACHEL ELIZABETH |4 aut | |
| 700 | 0 | |a PATEL JIGNA DHANU |4 aut | |
| 700 | 0 | |a PATEL SHIVANGI AKASH |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 06. März |
| 773 | 1 | 8 | |g year:2024 |g day:06 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/81654573/publication/EP4329733A1?q=EP4329733 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 06 |c 03 | ||